Skip to main content
. Author manuscript; available in PMC: 2012 Aug 27.
Published in final edited form as: Ann Rheum Dis. 2012 Jan 20;71(7):1157–1162. doi: 10.1136/annrheumdis-2011-200493

Table 3.

Disease characteristics of rheumatoid arthritis patients

Mean DAS28 4.68±1.86
Median DAS28   4.65±3.44
Disease duration 12.8±9.6
TNF-inhibitor (% yes) 35%
Methotrexate (% yes) 75%
Other Biologic (% yes) 20%
Other non-biologic DMARD (% yes) 23%
Prednisone use (% yes) 23%

DAS28, disease activity score using a 28 joint count (median DAS28±IQR, mean DAS28±SD); DMARD, disease-modifying antirheumatic drug; TNF, tumour necrosis factor.